Advancement in technology has nurtured the new era of genetic tests for personalized medicine. In this chapter, we will introduce the current development, challenges, and the outlook of genetic test, disease risk prediction, and genetic counseling. In the first section, we will present the success cases in the areas of molecular classification of tumors, pharmacogenomics, and Mendelian disorders, and the challenges of genetic tests implementations. In the second section, common methods for genetic risk prediction models and evaluation measures will be introduced, as well as challenges in feature reliability, risk model stability, and clinical utility. In the final section, key components of genetic counseling will be introduced, covering individual communications, psychosocial concerns, risk assessments, and follow-ups. Current evidences have shown a promising future for genetic testing and risk prediction; we expect that the advancement of analytical methods, technology, integration of omics data, and the increasing clinical implementation and regulation will continue to pave the way for precision medicine in future.
Genetic test Disease risk prediction Genetic counseling
This is a preview of subscription content, log in to check access.
McCarthy MI, et al. Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nat Rev Genet. 2008;9(5):356–69.CrossRefPubMedGoogle Scholar
National Research Council (U.S.). Committee on A Framework for Developing a New Taxonomy of Disease. Toward precision medicine: building a knowledge network for biomedical research and a new taxonomy of disease. Washington, DC: National Academies Press (US); 2011.Google Scholar
Hastie T, Tibshirani R, Friedman JH. The elements of statistical learning : data mining, inference, and prediction, Springer series in statistics. 2nd ed. New York: Springer; 2009. xxii, 745 pCrossRefGoogle Scholar
Steyerberg, E.W., et al., Assessing the performance of prediction models: a framework for some traditional and novel measures. Epidemiology (Cambridge, MA), 2010. 21(1): p. 128.Google Scholar
Pencina MJ, D’Agostino RB, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2008;27(2):157–72.CrossRefPubMedGoogle Scholar
Paulsen JS, et al. Prediction of manifest Huntington’s disease with clinical and imaging measures: a prospective observational study. Lancet Neurol. 2014;13(12):1193–201.CrossRefPubMedPubMedCentralGoogle Scholar
Langbehn DR, et al. A new model for prediction of the age of onset and penetrance for Huntington’s disease based on CAG length. Clin Genet. 2004;65(4):267–77.CrossRefPubMedGoogle Scholar
Pharoah PD, et al. Polygenes, risk prediction, and targeted prevention of breast cancer. N Engl J Med. 2008;358(26):2796–803.CrossRefPubMedGoogle Scholar
Meads C, Ahmed I, Riley RD. A systematic review of breast cancer incidence risk prediction models with meta-analysis of their performance. Breast Cancer Res Treat. 2012;132(2):365–77.CrossRefPubMedGoogle Scholar
Mega JL, et al. Genetic risk, coronary heart disease events, and the clinical benefit of statin therapy: an analysis of primary and secondary prevention trials. Lancet. 2015;385(9984):2264–71.CrossRefPubMedPubMedCentralGoogle Scholar
Thanassoulis G, et al. A genetic risk score is associated with incident cardiovascular disease and coronary artery calcium the Framingham heart study. Circ Cardiovasc Genet. 2012;5(1):113–21.CrossRefPubMedPubMedCentralGoogle Scholar
Ganna A, et al. Multilocus genetic risk scores for coronary heart disease prediction. Arterioscler Thromb Vasc Biol. 2013;33(9):2267–72.CrossRefPubMedGoogle Scholar
Beaney KE, et al. Clinical utility of a coronary heart disease risk prediction gene score in UK healthy middle aged men and in the Pakistani population. PLoS One. 2015;10(7):e0130754.CrossRefPubMedPubMedCentralGoogle Scholar
Liu DJJ, Leal SM. A novel adaptive method for the analysis of next-generation sequencing data to detect complex trait associations with rare variants due to gene main effects and interactions. PLoS Genet. 2010;6(10):e1001156.CrossRefPubMedPubMedCentralGoogle Scholar
Abul-Husn NS, et al. Implementation and utilization of genetic testing in personalized medicine. Pharmacogenomics Pers Med. 2014;7:227–40.Google Scholar
Harris A, Kelly SE, Wyatt S. Counseling customers: emerging roles for genetic counselors in the direct-to-consumer genetic testing market. J Genet Couns. 2013;22(2):277–88.CrossRefPubMedGoogle Scholar
Wang MH, Weng H, Sun R, Lee J, Wu WK, Chong KC, Zee BC. A Zoom-Focus algorithm (ZFA) to locate the optimal testing region for rare variant association tests. Bioinformatics. 2017;33(15):2330–2336. doi:10.1093/bioinformatics/btx130.